- Organization name
- UDI-DI code
- Reference / catalog number
IN-MF-000035953CancerCheck Core Panel is an IVDD-legacy in vitro diagnostic registered in EUDAMED. It is classified as IVDD — General. Manufactured by Genes 2Me Private Limited. Placed on the EU market in Belgium. Explore certificates, regulatory status and the EUDAMED record on MD Atlas.
EUDAMED last updated this device on Jun 25, 2025
B-G2MCC02001E4Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
D-G2MCC02001E4
DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA / IFA support is coming.
Sterile
A sterile device is supplied free of viable micro-organisms — flagged so that it is handled, stored and used to preserve that sterile state.
Single-use device
A single-use device is intended to be used on one patient during a single procedure and then discarded — not reprocessed or reused.
Primary placement in Belgium; available across 32 countries total.
| Country | On market since | Until |
|---|---|---|
| BelgiumPrimary placement | May 10, 2023 | Still on market |
| Austria | May 10, 2023 | Still on market |
| Bulgaria | May 10, 2023 | Still on market |
| Cyprus | May 10, 2023 | Still on market |
| Czechia | May 10, 2023 | Still on market |
| Germany | May 10, 2023 | Still on market |
| Denmark | May 10, 2023 | Still on market |
| Estonia | May 10, 2023 | Still on market |
| EL | May 10, 2023 | Still on market |
| Spain | May 10, 2023 | Still on market |
| Finland | May 10, 2023 | Still on market |
| France | May 10, 2023 | Still on market |
| Croatia | May 10, 2023 | Still on market |
| Hungary | May 10, 2023 | Still on market |
| Ireland | May 10, 2023 | Still on market |
| Iceland | May 10, 2023 | Still on market |
| Italy | May 10, 2023 | Still on market |
| Liechtenstein | May 10, 2023 | Still on market |
| Lithuania | May 10, 2023 | Still on market |
| Luxembourg | May 10, 2023 | Still on market |
| Latvia | May 10, 2023 | Still on market |
| Malta | May 10, 2023 | Still on market |
| Netherlands | May 10, 2023 | Still on market |
| Norway | May 10, 2023 | Still on market |
| Poland | May 10, 2023 | Still on market |
| Portugal | May 10, 2023 | Still on market |
| Romania | May 10, 2023 | Still on market |
| Sweden | May 10, 2023 | Still on market |
| Slovenia | May 10, 2023 | Still on market |
| Slovakia | May 10, 2023 | Still on market |
| Türkiye | May 10, 2023 | Still on market |
| XI | May 10, 2023 | Still on market |
Primary DI
The Primary DI is the main UDI-DI a manufacturer designates as the principal identifier for a device in EUDAMED.
D-G2MCC02001E4Basic UDI-DI
The Basic UDI-DI is the main identifier that groups together all device variants of the same model — the regulatory "family" key.
B-G2MCC02001E4G2MCC02001-ill; G2MCC02001-TF; G2MCC02001-MGUDI issuing entities
Issuing entities are the organisations the European Commission has designated to assign Unique Device Identifiers under the EU's UDI system.
IVDR risk classes
IVDR risk classes rank in-vitro diagnostic devices from lowest risk (Class A) to highest (Class D), based on the patient and public-health risk of a wrong result.
European Medical Device Nomenclature — the EU product classification assigned to this device.
W01060299TESTS FOR ACQUIRED GENETIC OR CHROMOSOMAL ALTERATIONS - OTHERB-G2M803321FCOn the marketC. Albicans-Q Real- Time PCR KitB-G2M708021FKOn the marketCancerCheck 50 PanelB-G2MCC03001EBOn the marketChikungunya-Q Real- Time PCR Test KitB-G2M705321FDOn the marketClinical Exome Sequencing (CES) Expanded PanelB-G2MCES07001KDOn the marketCommon Hereditary Cancer NGS PanelB-G2MCHC24001EHOn the marketNo certificate specifically references this device's Basic UDI-DI.
No certificates registered for this manufacturer.
No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.